NorthStar Medical Radioisotopes Announces Supply Agreement w

NorthStar’s high purity non-carrier-added (n.c.a.) Ac-225 to be used in advancing Nucleus’ partners radioligand therapies to treat cancer 

Related Keywords

Charless Conroy , Frank Scholz , Northstar Medical Radioisotopes , Manufacturing Organization , Contract Development , Nucleus Radiopharma , Chief Executive Officer , Northstar Medical , Drug Master File ,